bijwerkingen clozapine¶
Table 10. Adverse Reactions (≥2%) Reported in CLOZARIL-treated Patients (N=842) Across all CLOZARIL Studies (excluding the 2-year InterSePTTM Study)
Body System Adverse Reaction*
CLOZARIL
N=842
Percentage of Patients
Body System Adverse Reaction*
Central Nervous System:
Drowsiness/Sedation 39
Dizziness/Vertigo 19
Headache 7
Tremor 6
Syncope 6
Disturbed Sleep/Nightmares 4
Restlessness 4
Hypokinesia/Akinesia 4
Agitation 4
Seizures (convulsions) 3†
Rigidity 3
Akathisia 3
Confusion 3
Fatigue 2
Insomnia 2
Cardiovascular:
Tachycardia 25†
Hypotension 9
Hypertension 4
Gastrointestinal:
Constipation 14
Nausea 5
Abdominal Discomfort/Heartburn 4
Nausea/Vomiting3
Vomiting 3
Diarrhea 2
Urogenital:
Urinary Abnormalities 2
Autonomic Nervous System:
Salivation 31
Sweating 6
Dry Mouth 6
Visual Disturbances 5
Skin:
Rash 2
Hemic/Lymphatic:
Leukopenia/Decreased WBC/Neutropenia 3
Miscellaneous:
Fever 4
Weight Gain 5
†Rate based on population of approximately 1700 exposed during premarket clinical evaluation of CLOZARIL.